The Patient-Centered Approach in Rheumatologic Painful Diseases: A Narrative Review.
acute pain
dexketoprofen
drugs fixed dose combinations (fdc)
multimodal analgesia
patient-centered approach
rheumatologic painful diseases
tramadol
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
19
12
2021
accepted:
12
02
2022
entrez:
28
3
2022
pubmed:
29
3
2022
medline:
29
3
2022
Statut:
epublish
Résumé
A patient-centric approach to pain control represents a paradigm shift in analgesia and one that is both easy to endorse but challenging to execute. As pain mechanisms become increasingly elucidated, the understanding of pain has changed to encompass its complexities. Multiple types and mechanisms of pain have been described, and pain must be seen through the subjective experience of the patient. Earlier descriptions of pain based on intensity are one-dimensional and do not fully encompass the experience of pain. Thus, treating rheumatology patients or any patient in pain requires an understanding of the primary or secondary nature of the pain, underlying conditions, and patient factors such as anxiety, depression, fearfulness, and catastrophizing, all of which can shape and change the nature of the pain. Further, it is important to manage patient expectations concerning chronic pain as complete pain relief may not be possible, but a Patient Acceptable Symptomatic State (PASS) may serve. Functional goals are often more meaningful to patients than pain scores. Pharmacologic therapy for pain must consider side effects as well as analgesia. Patient-centered pain control requires a focus on wellness and disease prevention, personalized care plans, education, support for self-care, and may involve coordination across disciplines to help the patient meet personally meaningful objectives. While patient-centric care has become a buzzword in modern medicine, it is extremely relevant and may be very beneficial to pain patients.
Identifiants
pubmed: 35340520
doi: 10.7759/cureus.22244
pmc: PMC8930453
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e22244Informations de copyright
Copyright © 2022, Perrot et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Eur J Pain. 2019 Jul;23(6):1117-1128
pubmed: 30793414
J Pain Res. 2016 Oct 31;9:909-916
pubmed: 27826213
Curr Med Res Opin. 2012 Feb;28(2):249-56
pubmed: 22181344
PLoS One. 2011;6(5):e20274
pubmed: 21629777
Best Pract Res Clin Rheumatol. 2019 Jun;33(3):101415
pubmed: 31703792
Pain. 2019 Jan;160(1):19-27
pubmed: 30586067
RMD Open. 2019 Aug 6;5(2):e001029
pubmed: 31452932
Pain. 2019 Jan;160(1):77-82
pubmed: 30586074
Pain. 2011 May;152(5):1090-1095
pubmed: 21444153
Ann Rheum Dis. 2016 Mar;75(3):552-9
pubmed: 25732175
Adv Ther. 2019 Oct;36(10):2618-2637
pubmed: 31485978
Phys Ther. 2011 May;91(5):765-76
pubmed: 21451090
Eur Spine J. 2016 Sep;25(9):2788-802
pubmed: 27376890
J Clin Pharm Ther. 2014 Feb;39(1):4-6
pubmed: 24383938
Basic Clin Pharmacol Toxicol. 2019 May;124(5):629-641
pubmed: 30484960
Pain. 2013 Feb;154(2):248-256
pubmed: 23265687
J Rheumatol. 2011 Aug;38(8):1720-7
pubmed: 21807792
Pain. 2000 Apr;85(3):317-332
pubmed: 10781906
Phys Ther. 2011 May;91(5):737-53
pubmed: 21451099
Clin Exp Rheumatol. 2021 May-Jun;39 Suppl 130(3):186-193
pubmed: 34001303
PLoS Med. 2009 Apr 7;6(4):e1000045
pubmed: 19360134
JAAPA. 2020 Aug;33(8):8-11
pubmed: 32740106
Nat Rev Rheumatol. 2021 Jan;17(1):59-66
pubmed: 33116279
Cochrane Database Syst Rev. 2017 Apr 24;4:CD011279
pubmed: 28436583
J Clin Med. 2021 Nov 18;10(22):
pubmed: 34830649
Pain. 1993 Feb;52(2):157-168
pubmed: 8455963
Eur Spine J. 2004 Jul;13(4):332-40
pubmed: 14714246